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Abstract
Background: Prediction in high dimensional settings is difficult due to the large number of variables relative to the
sample size. We demonstrate how auxiliary ‘co-data’ can be used to improve the performance of a Random Forest in
such a setting.
Results: Co-data are incorporated in the Random Forest by replacing the uniform sampling probabilities that are
used to draw candidate variables by co-data moderated sampling probabilities. Co-data here are defined as any type
information that is available on the variables of the primary data, but does not use its response labels. These
moderated sampling probabilities are, inspired by empirical Bayes, learned from the data at hand. We demonstrate
the co-data moderated Random Forest (CoRF) with two examples. In the first example we aim to predict the presence
of a lymph node metastasis with gene expression data. We demonstrate how a set of external p-values, a gene
signature, and the correlation between gene expression and DNA copy number can improve the predictive
performance. In the second example we demonstrate how the prediction of cervical (pre-)cancer with methylation
data can be improved by including the location of the probe relative to the known CpG islands, the number of CpG
sites targeted by a probe, and a set of p-values from a related study.
Conclusion: The proposedmethod is able to utilize auxiliary co-data to improve the performance of a Random Forest.
Keywords: Classification, Random forest, Gene expression, Methylation, DNA copy number, Prior information
Background
High-dimensional prediction is inherently a difficult prob-
lem. In this paper we demonstrate how to improve the per-
formance of the Random Forest (RF) on high-dimensional
(in particular genomics) data by guiding it with ‘co-data’.
Here, co-data is defined as any type of qualitative or quan-
titative information on the variables that does not use the
response labels of the primary data. The primary data
may, for example, be a set of gene expression profiles with
corresponding binary response labels. Examples of co-
data are: p-values on the same genes in a external, related
study, correlations withmethylation or DNA copy number
data, or simply the location on the genome. Guiding a pre-
diction model by co-data may lead to improved predictive
performance and variable selection.
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Several methods are able to incorporate co-data dur-
ing model training. A general multi-penalty approach
was suggested by [1], a weighted lasso by [2], and a
group-regularized ridge by [3]. These methods are all
based on penalized regression, with a penalty parameter
that is allowed to vary depending on the co-data, effec-
tively rendering co-data based weights. The group-lasso
[4] and sparse group-lasso [5] are also regression-based,
but these methods apply a specific group-penalty that
can exclude entire groups of variables. Except for the
group-regularized ridge, all these methods allow for only
one type of co-data. In addition, except for the weighted
lasso, these methods require the co-data to be specified
as groups. The weighted lasso can handle one source of
continuous co-data, but requires an assumption about the
functional form of the penalty weighting and the co-data.
For some types of co-data this functional form is largely
unknown. Hence, it may be desirable to learn it from the
co-data, and to enforce monotonous weights to ensure
stability and interpretability.
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
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The Random Forest (RF) is a learner that is popular due
to its robustness to various types of data inputs, its abil-
ity to seamlessly handle non-linearities, its invariance to
data transformations, and its ease of use without any or
much tuning [6]. The RF is suitable and computationally
efficient for genomics data, with typically the number of
variables, P, largely exceeding the sample size, n [7, 8].
Its scale invariance makes it a good candidate to analyse
RNASeq data. Due to the skewed nature of such data, their
analysis is less straightforward with penalized regression
techniques and results depend strongly on the data trans-
formation applied [9]. Our aim is to develop a co-data
moderated RF (CoRF) which allows the joint use of mul-
tiple types of co-data, the use of continuous co-data, and
flexible modeling of the co-data weights. Conveniently,
these co-data are only used when training the classifier;
they are not required for applying the classifier to new
samples.
The described methodology can in principle be used
with any bagging classifier that uses the random subspace
method [10], but in this paper we focus on the RF. The
method is exemplified with two examples. First, we aim to
predict the presence of a lymph node metastasis (LNM)
for patients with head and neck squamous cell carci-
noma (HNSCC) using TCGARNAseq data.We show how
the use of several types of co-data, including DNA copy
number, an external gene signature and mRNA microar-
ray data from an independent patient cohort, improves
the predictive performance, and validate these results on
a second independent data set. The computational effi-
ciency of the method is illustrated with a second example,
where our aim is to predict the last precursor stage for
cervical cancer based on methylation data with very large
P ≈ 350.000. The co-data in this example consists of the
location of the methylation site, the number of CpGs, and
the external set of p-values.
Methods and Results
Random forest
The aim of a supervised RF is to predict per sample
i, i = 1, . . . , n, an outcome Yi using a set of variables Xij
where j = 1, . . . ,P indicates the variables. Here, we focus
on binary outcome Yi, although the entire methodology
and software also applies to continuous and censored (e.g.
survival) outcomes. A RF consists of a large number of
unpruned decision trees, where each tree is grown on a
bootstrap sample of the data. At each node split in each
tree only a random subset of the variables are candidates,
its size denoted bymtry, typically set at
√
P. In a standard
RF, all variables have an equal probability of being candi-
dates. Predictions are issued by majority voting across all
trees, or on a fractional scale (fraction of trees predicting
Yi = 1). We will use the latter for assessing predictive per-
formance. A RF is fitted to a bootstrap sample of the data
implying that per tree the remaining fraction (on aver-
age 0.368) is out-of-bag (oob) and can be used to obtain
an estimate of the prediction error. This leads to a com-
putational advantage compared to methods that require
cross-validation for this purpose.
Group-specific probabilities
We first briefly describe our method using one source of
grouped co-data only. Here, the basic idea is that, when an
a priori grouping of variables is available (co-data), wemay
sample the variables according to group-specific probabil-
ities, and these probabilities can be estimated empirically
from the data.When the number of groups is limited, only
a few parameters need to be estimated (the group specific
probabilities). Especially when the difference in predictive
power between groups of variables is large, the predictive
performance may be enhanced.
In practice, this means we first need to run a base RF (i.e.
uniform sampling probabilities). From this initial fit, we
obtain the number of times each variable is used across all
trees. Then, the new group-specific probabilities wg are:
wg =
(
pˆselg − γ p0
)+
, (1)
where pˆselg is the proportion of selected variables from
group g across all trees divided by the size of group g and
p0 = 1/P is the expected value of pˆselg when the group
structure is uninformative. Parameter γ can be used to
tune the RF to adapt to group-sparsity by thresholding,
but may also be set to one to avoid tuning. After nor-
malizing wg such that these sum to one across variables,
we obtain sampling probabilities w˜g . Then, a new RF is
trained using these probabilities instead of the uniform
ones, rendering the CoRF.
Model-based probabilities
Next we extend the described method to allow for mul-
tiple sources of co-data, including continuous co-data.
Figure 1 schematically displays the method for the first
application. First, we enumerate all node splits in all
trees. Then, we define vjk as a binary variable indicating
whether or not variable j was used in the kth split, and
Vj = ∑k vjk as the total number of times that variable j
was used.
The main challenge in modeling multiple types of co-
data, is that the various types of co-data may be collinear.
We therefore need to de-tangle how well the various types
of co-data explain vjk . For that, we use a co-datamodel.We
propose to use the logistic regression framework for this.
We denote the P × C co-data design matrix by X, where
Xjc contains the co-data information for the jth variable
and the cth co-data type, and where nominal co-data on
L levels is represented by L − 1 binary co-data variables.
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Fig. 1 Illustration of the sources of data used in CoRF for the LNM
example. First, a base RF is fitted on the training data. Its output, vij ,
together with the co-data, is used to train the co-datamodel. From the
co-data model, we obtain a probability per gene used for refitting on
the training data. In an extra step we validate the results on GSE84846
Then, vjk is Bernoulli distributed with vjk ∼ Bern(pj), and
we estimate pj using a logistic regression:
logit(pj) = α0 +
C∑
c=1
Xjcαc (2)
From the co-datamodel, we obtain a predicted probabil-
ity per variable, pˆj. Note that inclusion of the intercept α0
in (2) guarantees that
∑P
j=1 pˆj = 1, as desired. The logistic
regression establishes a marginal relationship between vjk
and Xjc. For modeling Vj, first note that vjk contains two
types of dependencies: (1) a dependency between splits k
for a given variable j, e.g. only one variable can be chosen
per split; (2) dependency between variables and therefore,
between their selection frequencies (Vj). The first depen-
dency is addressed by using a quasi-binomial likelihood
qBin(Vj;α, τ) for Vj = ∑k vjk , which allows for an over-
or under-dispersion parameter τ by modeling Var(Vj) =
τpj(1 − pj) [11]. We do not explicitly address the second
type of dependency, which implies that the estimation is
based on a pseudo-log-likelihood:
(
αˆ, τˆ
) = max
α,τ
⎡
⎣
P∑
j=1
log
(
qBin
(
Vj;α, τ
)
⎤
⎦ . (3)
As a result the uncertainties of the estimates and the
p-values of the co-data model do not have a classical inter-
pretation, and cannot directly be used for inference. We
are, however, primarily interested in the point estimates,
pˆj, obtained by substituting αˆ into (2), which are used to
re-weigh variables:
wj =
(
pˆj − γ p0
)+ . (4)
As earlier, γ can be set to 1 which provides a natural
cut-off for p0, or γ may be tuned to more or less sparsity.
Finally, we normalize wj to obtain the sampling proba-
bilities w˜j = wj/∑j wj, which are then used to re-train
the RF.
The relationships we are interested in are often non-
linear, e.g. for external p-values the difference between
10−4 and 10−2 may be more relevant than that between
0.25 and 0.50. We therefore extend the linear model (2)
to include more flexible modeling of continuous co-data
with a monotonous effect, which is often natural and
desirable. For that, we fit a generalized additive model
with a shape constrained P-spline (SCOP, [12]), as imple-
mented in the R package scam. Then, Eq. (2) becomes
logit(pj) = α0 +
C1∑
c=1
Xnjcαc +
C2∑
d=1
fd
(
Xcjd
)
(5)
where Xn (Xc) denotes the sub-matrix of X containing the
nominal (continuous) co-data, and fd() represents a flex-
ible function provided by the SCOP. To model fd, SCOP
uses m(x) = ∑q=1 θB(x), where B is a B-spline basis
function, which is monotonously increasing when θ ≥
θ−1,  = 1, . . . , q [12]. The monotony in θ is enforced by
defining θ = θ˜ , where θ˜ =[ θ˜1, exp(θ˜2), . . . , , exp(θ˜q)]T
and rs = 0 if r < s and rs = 1 if r  s. Smooth-
ness is enforced by penalisation of the squared differences
analogous to [13]. Setting rs = −1 for r  s renders a
monotonically decreasing spline. Unrestricted splines can
in principle also be used in the co-data model, but are
more liable to over-fitting.
Instead of using the default of γ = 1, this parameter
can be tuned by a grid search. This requires calculating wj
and refitting a RF for each grid-value of γ . The optimal
value of γ is then the one with the best oob performance.
Note that tuning γ with the oob predictions may result in
a degree of optimism. This may be solved by embedding
the procedure in a cross-validation loop. When γ is not
tuned, the oob performance of CoRF may also be slightly
optimistic, because the primary data was used to estimate
the weights (4). However, when the regression model (2)
is parsimonious, the overoptimism is likely small, as veri-
fied empirically in the Application section. To ensure that
the co-data model is parsimonious, it may be useful to
perform co-data selection to remove redundant co-data
sources, which also assists in assessing the relevance of
the co-data. The Additional file 1 supplies an heuristic
procedure to do so.
CoRF algorithm
The CoRF procedure may by summarized as follows:
1. Fit a base RF with uniform sampling probabilities and
obtain vjk .
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2. To disentangle the contributions of the various
co-data sources.
• Fit co-data model (2), if only linear effects are
assumed.
• Fit co-data model (5) with shape constrained
P-spline(s), if flexible, monotone effects are
required.
• Optionally: exclude redundant co-data sources
and re-fit the co-data model.
3. Obtain the predicted probabilities pˆj from the fitted
co-data model.
4. Calculate the sampling probabilities wj with
threshold parameter γ . Default is to set γ = 1,
optionally γ can be tuned.
5. Refit the RF for each vector of w˜j.
6. • If γ is not tuned (i.e. γ = 1), we directly obtain
the CoRF, the base RF and their oob
performances.
• If γ is tuned, obtain γˆ by maximizing the oob
performance. Tuning γ may introduce a bias in
the oob performance. Hence, the entire
procedure is cross-validated when γ -tuning is
employed.
Implementation
The method as described here is implemented in
a corresponding R package, called CoRF, and is
available on GitHub. It depends on the R package
randomForestSRC for fitting the RF [14–16]. A feature
of this package that is of key importance for CoRF is
the option to assign a sampling probability per variable.
In addition, randomForestSRC applies to regression,
classification and survival analysis, and by extension, so
does CoRF.
For classification by the RF the recommended mini-
mal node size is one. The node size can be tuned [17],
but a RF is not very sensitive to the minimal node size.
In CoRF the quality of the selected variables may influ-
ence the fit of the co-data model. Variables that are used
higher up in a tree are, on average, more relevant, and
variables that split a node of size 2 are the least relevant.
For CoRF, we believe it is better to slightly increase the
minimal node size, improving the quality of the selected
variables and as a result improve the quality of the co-data
model. As default in CoRF, we set the minimal node size
for classification at 2.
Generally, CoRF will need a larger number of trees to fit
than a base RF. A base RF needs enough trees to capture
the underlying signal in the data. CoRF additionally needs
an indication of the relevance of each variable, which feeds
back to the co-data model. Also, a co-data model that con-
tains splines generally needs more trees than a co-data
model with only linear effects. In the LNM example,
described below, we set the number of trees at 15.000 to
ensure convergence of both the RF/CoRF and the co-data
model. A lower number of trees, e.g. 2.000, gives a similar
result in terms of predictive performance, but the variabil-
ity between fits increases. When using CoRF, we recom-
mend to use at least 5.000 trees to ensure a reliable, good
fit of the co-data model. An additional advantage of a large
number of trees with tuning is that the variability between
RF fits decreases, allowing for a more reliably selection
of γ .
A RF is a computationally efficient algorithm to use for
high dimensional data, primarily because at each node it
selects only from
√
P variables. CoRF inherits this effi-
ciency and when the default γ = 1 is used, only one RF
refit is needed. Next to (re)fitting the RF, the only addi-
tional computation required for CoRF consists of fitting
the co-data model. Further tuning of γ may improve the
performance, but also requires i) refitting a RF for each
value for γ , and ii) an additional cross-validation loop
to assess performance, thereby increasing computational
cost considerably.
Evaluating predictive performance
The predictive performance of CoRF and other classi-
fiers was assessed on oob samples by two metrics: i) the
area-under-the-roc curve (AUC; [18]); and ii) the Brier
score [19]. AUC is based on ranks and evaluates discrim-
ination. It combines sensitivity and specificity, which are
both important in a clinical setting. Moreover, it is a good
indicator for the performance of a RF with unbalanced
data [18]. Brier score is based on residuals and evalu-
ates calibration. It equals the average Brier residual, i.e.
Bi = (Yi − qi)2, where qi is the fraction of trees predict-
ing Yi = 1. Brier score is reported in a relative sense, with
the base RF as benchmark. For comparing CoRF with RF
we implemented significance testing, both for AUC: the
difference between AUCs, using R’s pROC package [20]
and for Brier: the difference between Brier scores, using
the one-sided Wilcoxon signed-rank test on paired Brier
residuals
(
BRFi ,BCoRFi
)
. When performance was evaluated
on the same data as used for training, we usedmultiple 2/3
- 1/3 splits, meaning that the power for testing, for which
only 1/3 of the samples can be used, can be limited. These
splits result in multiple p-values, which we aggregate by
applying themedian, which was proven to control the type
I error rate under mild conditions [21].
Similarly to the base RF, CoRF automatically renders
oob predictions. CoRF is an empirical Bayes-type classi-
fier, which uses the relation between the co-data and the
primary data to estimate sampling weights. Such double
use of data could lead so some degree over overopti-
mism, although this will likely be limited given that the
co-data model is parsimonious. In addition, when splines
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were used, the effective degrees-of-freedom were reduced
by imposing monotony. Nevertheless, in the examples
below, we verified the oob performance of CoRF by cross-
validation when training and evaluation was applied on
the same data.
Comparable methods
To our knowledge, there is only one high-dimensional pre-
diction method that can explicitly take multiple sources
of co-data into account: the group-regularized (logistic)
ridge (GRridge [3]). CoRF provides several conceptual
advantages over GRridge. First, unlike CoRF, GRridge
requires discretisation of continuous co-data. Second,
CoRF fits the co-data coefficients in one model, (2),
instead of using the co-data sources iteratively. Third,
CoRF is computationally more efficient, because it a)
inherits the better computational scalability of RF with
respect to P; and b) requires very little tuning and no iter-
ations. Finally, as with a base RF, CoRF is naturally able
to incorporate categorical outcomes with > 2 groups (as
demonstrated in the cervical cancer example). GRridge
inherits the advantages of ridge regression, e.g. better
interpretability of the model and the ability to include
mandatory covariates. In the Application section we com-
pare the performances of these two methods for the LNM
example.
Applications
Predicting Lymph nodemetastasis with TCGA data
To exemplify the CoRF method, we use it to predict the
presence of a lymph node metastasis (LNM) for patients
with HPV negative oral cancer using RNASeqv2 data from
TCGA [22]. We focus on the HPV-negatives, because
these constitute the majority (approx. 90%) of the oral
cancers, and HPV-positive tumors are known to have a
different genomic etiology [23]. Early detection of LNM is
important for assigning the appropriate treatment. Diag-
nosis of LNM with genomic markers could potentially
improve diagnosis and treatment [24].
The primary data consists of normalized TCGA
RNASeqv2 profiles of head-and-neck squamous cell carci-
nomas (HNSCC), which were downloaded together with
thematching normalized DNA copy number co-data from
Broad GDAC Firehose using the R package TCGA2STAT.
Of the 279 patients described in [22], we used the sub-
set of 133 patients that had HPV-negative tumors in the
oral cavity. Of these patients, 76 presented a LNM and 57
did not.
To enhance the prediction of the base RF, we consider
three types of co-data in this example: (1) DNA copy
number; (2) p-values from the external microarray data
GSE30788/GSE85446; (3) a previously identified gene sig-
nature [24–26]. These three types of co-data demonstrate
the variety of co-data sources that can be included in
CoRF. The DNA copy number data are measurements on
the same patients. We use the cis-correlations between
DNA copy number and the RNASeqv2 data. Given the
nature of RNASeqv2 and DNA copy number data (dis-
crete and ordinal, respectively), we applied Kendall’s τ to
calculate the correlations, giving τj, j = 1, . . . ,P. Note
that the DNA data are only used during training of the
predictor; these are not required for test samples, which
distinguishes this type of predictor from integrative pre-
dictors [27]. The p-values of GSE30788/GSE85446 are
derived frommeasurements of the same type of genomics
features (mRNA gene expression), but measured on a
different platform (microarray) than that of the primary
RNAseq data and on a different set of patients. The gene
signature is a published set of genes that were found to be
important in a different study. Figure 1 illustrates how the
various types of data are used within CoRF.
Each type of co-data has its own characteristics that
needs to be taken into account in the co-data model. For
the DNA copy number data, we a priori expect that a
gene with a positive cis-correlation is more likely to be
of importance to the tumor [28]. We use a monotonically
increasing spline f1 to model the relation between pj and
Xcj1 = τj (5). For the p-values of GSE30788/GSE85446,
we a priori expect that genes with a low p-value are more
likely to be important on the TCGA data, and we thus use
a monotonically decreasing spline f2 to model the relation
between pj andXcj2 = pvalj. The third type of co-data, con-
sisting of the published gene signature is included in the
co-data model (2) as a binary variable: Xnj1 = 1 when gene
j is part of the signature, and 0 otherwise.
Data set GSE30788/GSE85446 consists of 150 Dutch
patients (of which 60 presented a LNM and 90 did not)
with a HPV-negative oral cancer tumor who are in that
respect similar to the TCGA patients. Gene expression
was measured by microarray, the p-values on GSE30788/
GSE85446 were calculated using a Welch two-sample t-
test; further details on the study can be found in [29].
The differences between the TCGA and the Dutch data
(notably the platform and the geographical location of the
patients) preclude a straightforward meta-analytic data
integration. Also, our focus here is on the TCGA data,
which were measured on a more modern platform, but
shared genomic features with the Dutch co-data may
enhance the weighted predictions.
After training the base RF and the CoRF, we validate
these classifiers on an independent data set (GSE84846).
GSE84846 contains microarray expression data of 97
HPV-negative oral cancer patients from Italy, of whom
49 had a LNM [29]. To directly apply the classifiers to
the validation data, we need to account for the differ-
ences in scale between RNASeqv2 and microarray data.
First, the TCGA RNASeqv2 data are transformed by the
Anscombe transformation (i.e.
√
(x + 3/8)). Next, both
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the TCGA RNASeqv2 and GSE84846 data are scaled to
have zero mean and unit variance. We only included
genes that could uniquely be matched between the two
data sets (leaving 12838 genes). Since this validation does
not require any re-training, the performance is directly
assessed by comparing the predictions with the actual
labels. As an alternative to this validation, we also use
the relative frequency of variables used by the base RF
and CoRF on the TCGA data as sampling probabilities in
training a new RF on GSE84846 data, in which case the
oob-performance was used.
We also assess the performance of the base RF and
CoRF in terms of variable selection on both the train-
ing and validation data sets. For the TCGA training data
set, we first select a set of genes (based on Vj), retrain
on this subset, and assess the performance with a 10-fold
cross-validation. For the validation data set, we first select
variables on the TCGA training data with the variable-
hunt-vimp (vh-vimp) as described by [30]. Roughly, vimp
measures the importance of a variable by assessing the
decrease in predictive performance when the values of
the variable are ‘noised up’, e.g. randomly permuted across
samples. Then, we refit with the selected set of variables
on the TCGA training data, and evaluate the performance
of the refitted model on the validation data using oob-
performance. To assess the stability of variable selection
with a base RF and CoRF, we repeatedly (20 times) sam-
ple 84 out of 133 TCGA cases without replacement and
fit a base RF and CoRF to each sampled set. Note that
the sampling fraction mimics the expected fraction of
independent samples in a re-sampling scheme, 0.632. We
preferred subsampling over resampling here, because the
latter would lead to duplicate samples in the sampled set.
Stability of gene selection was then assessed by calculating
the average overlap between any combination of two sets
of variables selected from the subsampled training sets,
varying the sizes of the selection sets from 10, 20, . . . , 100
genes.
Performance on LNM example
By examining the fit of the co-data model (Fig. 2), we
observe that pˆj is estimated higher for genes with a
high cis-correlation, for genes with a low p-value on
GSE30788/GSE85446, and for genes that are present in
the gene signature. By prioritising these genes we observe
an improvement in oob-AUC (base RF: 0.682, CoRF:
0.706) and a relative decrease in oob-Brier score of 2.7%.
Figure 3a and b show the ROC-curves (specificity versus
sensitivity), parametrized by a threshold for the propor-
tion of trees predicting LNM.When assessing significance
using ten 2/3 - 1/3 splits, rendering an effective test sam-
ple size of ntest = n/3 ≈ 44, the median p-values equal
p˜AUC = 0.255 and p˜Brier = 0.034, hence significant
at α = 0.05 for the latter. In terms of Brier residuals,
predictions improved for 27.2 out of 44 test samples, on
average across splits. With 10-fold cross-validation we
also see an improvement by using CoRF (cv-AUC base RF:
0.675, CoRF: 0.690). On the validation data we find that
CoRF renders a slightly larger improvement (AUC base
RF: 0.652, CoRF: 0.682); here the Brier score decreases by
2.6%. In this case we may use all 97 samples for signifi-
cance testing. Then, the resulting p-values are: pAUC =
0.056 and pBrier = 0.0048, hence close to significant
for the first and significant for the latter metric. In terms
of Brier residuals, predictions improved for 64 out of 97
samples.
Retraining on the validation data using only the sam-
pling probabilities derived from either the base RF/CoRF
fits to the TCGA data yields a similar result (oob-AUC
base-RF: 0.656, CoRF: 0.695). From Fig. 4 we observe that
CoRF also improves the oob-AUC when applying variable
selection to both the training and validation data. Finally,
stability of gene selection, when selecting genes with the
vh-vimp measure, increased by 17%, averaged across sizes
of the selection sets. This means that when selecting genes
using random subsets of samples the overlap between
two selected sets of equal size is on average substantially
higher with CoRF than with RF. For gene selection with
Vj the average stability increased by 36%. For these data,
tuning of γ does not improve results, see Additional file 1.
For comparison with GRridge, we find a cv-AUC of
0.682 on the training data and AUC of 0.689 on the val-
idation data. With GRridge the global penalty parameter
of the ridge regression was estimated using a 10-fold
cross-validation and performance on the training data was
assessed using a second 10-fold cross-validation. For the
validation data we directly applied the resulting classi-
fier. In performance this is comparable to CoRF, but note
that CoRF is quicker, especially when we want an estimate
of the prediction error (see the “Computational time”
section).
Cervical cancer example
In this second example, our aim is to predict cervical
(pre-)cancer on a very high-dimensional methylation data
set. The methylation data consists of 365620 methylation
sites, and contains 68 samples of which 28 correspond
to normal cervical tissue, 36 have a high-grade precur-
sor lesion (CIN3; CIN = cervical intraepithelial neoplasia)
and 4 have cervical cancer. A diagnosis of either of the lat-
ter two stages usually implies surgery. The samples were
taken using a self-sample test, implying a challenging diag-
nostic setting. The data used in this example originate
from [31] where more information can be found on the
clinical details and on the preprocessing of the methyla-
tion data. When training the RF, we consider the three
separate categories, while for the final prediction we add
up the votes for CIN3 and cancer, because of the small
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a b
Fig. 2 Fit of the co-data model for the LNM example. Each square represents 100 genes grouped by either (a) DNA copy number-expression
correlation or (b) p-value. The red lines represent the marginal fit across the correlations or p-values. The top red lines represent the fit for genes
present in the gene profile. The cloud of red dots represent the fitted values for 1000 randomly selected genes
sample size for the latter. As before, our aim is to improve
the prediction of the base RF by including co-data (e.g.
CoRF).
The co-data consists of the location of the probe rela-
tive to the known CpG islands (categorized in 6 classes,
including CpG-island), the number of CpG sites included
in the genomic location targeted by the probe, and
p-values, obtained by differential methylation analysis on
a related, external study [32]. The latter study also com-
pares methylation levels of normal cervical tissue (20)
versus CIN3’s (17), but on surgically obtained cervical tis-
sue. Hence, the setting is different than for our primary
self-sample study, but these co-data are possibly very use-
ful. The location of the probe is modeled as a nominal
variable in the co-data model. From the fit of the co-data
model (Fig. 5), we observe that the location of probe has as
strong effect on pˆj, and indeed CpGs located within a CpG
island are most important. The number of CpG sites can
be either modeled as a factor variable or with a monoton-
ically increasing spline. We opted for the second option,
thus explicitly assuming that methylation sites with more
CpG sites are likely more relevant, which seems reason-
able when considering the fit of the co-data model (Fig. 5).
Note that modeling the number of CpG sites as a factor
variable gave a similar result.
Finally, for the external p-values we expect a differ-
ent co-data effect for methylation sites that were either
up- or down-regulated in the external co-data. We a
priori expect a stronger effect of probes that are up-
regulated, because down-regulated effects in the tissue
a b c
Fig. 3 The ROC curve based on oob predictions for the base RF and CoRF. The ROC curve based on oob predictions for the base RF and CoRF; (a)
the TCGA training data, (b) validation data set (GSE84846), and (c) The cervical cancer example
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Fig. 4 The performance of RF/CoRF for given numbers of variables
selected with vh-vimp for the LNM example. For the (TCGA) training
data the performance was assessed by a 10-fold cross-validation. For
the validation data set (GSE84846) the prediction models where
directly applied
data are hard to discover in self-samples, due to likely
contamination of affected samples by adjacent normal tis-
sue. We accommodate this distinction by modeling the
interaction between the p-value and the direction of regu-
lation (both obtained from the co-data), essentially fitting
two monotonically decreasing splines, one for up- and
one for down-regulated methylation sites. We indeed find
that there is an effect of the p-values for the up-regulated
methylation sites (Fig. 5). For the the p-values of the down-
regulated methylation sites, the co-data model did indeed
not identify an effect.
For this diagnostic setting, we observe there is an
improvement by using CoRF (oob-AUC base RF: 0.666,
CoRF: 0.710) and a decrease in oob-Brier score of 4.6%.
Fig. 3c shows the ROC-curves (specificity versus sensi-
tivity), parametrized by a threshold for the proportion
of trees predicting CIN3/Cancer. When using ten 2/3 -
1/3 splits, rendering an effective test sample size of only
ntest = n/3 ≈ 23, the median p-values equal p˜AUC =
0.351 and p˜Brier = 0.065, hence close to significant at
α = 0.05 for the latter. In terms of Brier residuals, predic-
tions improved for 14.5 out of 23 test samples, on average
across splits. With 10-fold cross-validation we find a simi-
lar increase in AUC (cv-AUC base RF: 0.661, CoRF: 0.702).
In this case tuning rendered a value of γ = 1.7, which
excluded all but 105 variables. Tuning increased the cross-
validated performance to AUC = 0.737 (See Additional
file 1).
Computational time
When using 5000 trees and without tuning of γ , the LNM
example (n = 133, P = 12838) runs in 1:18 min (single
threaded on a E5-2660 cpu with 128 gbmemory). The cer-
vical cancer example (P ≈ 350.000, n = 68) runs 22:24
min, of which the co-data model takes 8 min. By com-
parison, fitting a GRridge (R package GRridge) with a
a b c
Fig. 5 Fit of the co-data model for the cervical cancer example. Displayed are the estimated sampling probabilities for 10000 randomly selected
methylation sites displayed by (a) location of the methylation site, (b) the number of CpGs, and (c) p-values. Figure c only displays the methylation
sites that are up-regulated
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10-fold cross-validation to estimate the global λ takes 2:07
min for the LNM example and 35:12 min for the cervi-
cal cancer example. To estimate the predictive error by
cross-validation with GRridge the respective times need
to be multiplied by the number of folds, rendering it much
slower than the default CoRF (γ = 1), which does not
require cross-validation.
Discussion and conclusion
The LNM and cervical cancer examples demonstrate that
CoRF is able to improve the base RF by using co-data. Of
course, the amount of improvement relates directly to the
relevance of the co-data for the data at hand. The co-data
are relevant if, for example, some of the co-data groups
contain a relatively large number of variables related to
the outcome, or if a continuous source of co-data (e.g.
external p-values or correlations with other genomic mea-
surement) correlates strongly with the importance of a
variable. Figures 2 and 5 show the relevance of the co-
data for our examples. Including additional informative
co-data could further increase the performance of CoRF.
Hence, expert knowledge on the domain and available
external data is crucial. In addition, stability of the set of
selected variables increased by the use of CoRF. We argue
that the use of co-data provides a stronger foundation for
the classifier, which may enhance generalization to other
measurement platforms, which is sometimes problematic
in omics settings.
If the co-data are non-relevant, CoRF provides a safe-
guard against over-fitting. Firstly, the co-data weights are
estimated from a parsimonious (2) or smooth (5) model
to ensure that they are stable. To further stimulate parsi-
mony, one may conduct the co-data selection procedure
described in the Additional file 1, which removes redun-
dant sources of co-data. Practically, the use of CoRF is
a bit more demanding than the use of RF: one needs to
think about what co-data could be of use, and invest time
in processing such co-data. On the other hand, this may
also be perceived as an advantage: the classification pro-
cess requires more involvement of the problem owner,
e.g. a clinician or molecular biologist, instead of being a
‘black box’.
CoRF essentially aims at reducing the haystack of
genomics variables by using co-data. Of course, one could
also use ad-hoc filtering methods to preselect variables
on the basis of existing information, but this intro-
duces a level of subjectivity and sub-optimality when
the threshold(s) are not chosen correctly. CoRF formal-
izes the weighting and thresholding process and lets the
data decide on the importance of a given source of co-
data. We expect CoRF to be most useful in (very) high-
dimensional settings. In such settings, variables likely
differ strongly in predictive ability while the size of the
haystack complicates the search. In such situations our
co-data approach can assist in identifying the relevant
variables. For P < n settings, the prediction model is
trained with a (relatively small) selected set of features.
This means that i) learners not supported by co-data (e.g.
base RF) are fairly well able to discriminate the important
variables from the non-important ones; and ii) the small P
complicates good estimation of our empirical Bayes-type
(sampling) weights. Hence, in such a situation, CoRF (and
co-data supported methods in general) are less likely to
boost predictive performance. CoRF is weakly adaptive in
that it learns the sampling weights from both the primary
and the co-data, in contrast to other adaptive methods
like the enriched RF [33] or the adaptive lasso [34], where
weights are inferred only from the primary data. In high-
dimensional applications such strong adaptation is more
likely to lead to over-fitting, unlike the co-data moderated
adaptation.
CoRF inherits its computational efficiency from the
RF. When the tuning-free version is used (γ = 1), we
empirically found that the oob performance suffices and
cross-validation is not required. This makes the method-
ology very suitable for applications with extremely large
P. Tuning of γ may slightly improve the predictive perfor-
mance, but at a substantial computational cost, given the
required grid search for γ and the additional CV loop. The
CoRF methodology may be combined with any bagging
classifier that uses the random subspace method, such as a
random glm [35] or a random lasso [36]. If variable selec-
tion is more stringent for a particular method (i.e. less
noisy), then identification of the relationships of the co-
data model may be easier. On the other hand, if most of
the variables are not used, then we are unable to obtain an
reliable assessment of the quality of those variables which
may complicate fitting the co-data model. One possible
extension of CoRF could be to use the depth at which vari-
ables are used by the RF, for example through the average
or minimal depth [30]. Variables that are used higher up
in a tree are, on average, more relevant, and it could be
beneficial to assign larger weights to these variables in the
co-data model. Another way of accomplishing this is to
replace vij by a measure that counts how often each vari-
able is used in classifying the oob samples, analogous to
the intervention in prediction measure [37, 38]. This mea-
sure naturally up-weights variables that are often high up
in a tree. We intend to investigate these matters in the
future.
Additional file
Additional file 1: Supplementary Files. Contains description about
automatic co-data selection, results on tuning γ and evaluation of
performance of CoRF with vimp. (PDF 288 kb)
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